CC BY-NC-ND 4.0 · Laryngorhinootologie 2019; 98(S 02): S76-S77
DOI: 10.1055/s-0039-1686026
Monotherapy with a A2A Adenosine Receptor Antagonist Reduces Tumor Volume in a 4-NQO-induced
Head and Neck Cancer (HNC) Mouse Model
S Ludwig
1
Hals-Nasen-Ohrenheilkunde, Universitätsklinik Essen, Essen
,
CS Hong
2
Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
B Razzo
2
Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
K Fabian
3
Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
M Chelvanambi
3
Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
S Lang
1
Hals-Nasen-Ohrenheilkunde, Universitätsklinik Essen, Essen
,
W Storkus
3
Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
,
T Whiteside
2
Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
› Author Affiliations
